JOVOLA - Trademark Details
Status: 710 - Cancelled - Section 8
Image for trademark with serial number 85261936
Serial Number
85261936
Registration Number
4651130
Word Mark
JOVOLA
Status
710 - Cancelled - Section 8
Status Date
2021-07-16
Filing Date
2011-03-09
Registration Number
4651130
Registration Date
2014-12-09
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2014-09-23
Attorney Name
John F. Ward
Law Office Assigned Location Code
M20
Employee Name
EULIN, INGRID C
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Goods and Services
Pharmaceutical preparations, namely, pharmaceutical preparations and substances for the treatment of skin disorders, diseases, conditions and ailments; pharmaceutical preparations and products for use in dermatology; antifungal preparations; pharmaceutical preparations and substances for the treatment of eye disorders, diseases, conditions and ailments; pharmaceutical preparations and products for ophthalmological use; pharmaceutical preparations and substances for the treatment of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety, depression, depressive disorders and mental illness; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardiovascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of Parkinson's disease; pharmaceutical preparations and substances for the prevention, treatment and alleviation of Huntington's disease; pharmaceutical preparations and substances for the prevention, treatment and alleviation of amyotropic lateral sclerosis; pharmaceutical preparations and substances for the prevention, treatment and alleviation of Alzheimer's disease; pharmaceutical preparations and substances for the prevention, treatment and alleviation of Tourette Syndrome; pharmaceutical preparations and substances for the prevention, treatment and alleviation of epilepsy; pharmaceutical preparations and substances for the prevention, treatment and alleviation of multiple sclerosis; pharmaceutical preparations and substances for the prevention, treatment and alleviation of cardio-pulmonary disorders, diseases, conditions, and ailments; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions, and ailments of the circulatory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension, high blood pressure, heart filure and ventricular dysfunction; pharmaceutical preparations and substances for the prevention, treatment and alleviation of metabolic disorders, diseases, conditions and ailments; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of viral and infectious diseases; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of central nervous system disorders, diseases, conditions and ailments, namely, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, cerebral palsy, insomnia, mood disorders, bipolar disorder, seizure disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations for the treatment of immunologic diseases, namely, auto immune motility diseases, immunologic deficiency syndromes, auto immune diseases, Acquired Immune Deficiency Syndrome (AIDS), hypersensitivity, allergies, tumors of the immunological organs; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculoskeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for the treatment of polycystic ovary syndrome; pharmaceutical preparations and substances for the treatment of infertility; metformin; diltiazem; tramadol; carvedilol; bupropion; metoprolol; citalopram; zolpidem; fluoxetine; venlafaxine; lorazepam; and sumatriptan
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
2 - Sec. 8 - Entire Registration
Class Status Date
2021-07-16
Primary Code
005
Correspondences
Name
John F. Ward
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing DateApplication NumberCountryForeign Priority Claim In
2011-03-08BarbadosFalse
0000-00-00BarbadosFalse
Trademark Events
Event DateEvent Description
2011-03-12NEW APPLICATION ENTERED IN TRAM
2011-03-14NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2011-04-06AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
2011-06-09ASSIGNED TO EXAMINER
2011-06-09NON-FINAL ACTION WRITTEN
2011-06-09NON-FINAL ACTION E-MAILED
2011-06-09NOTIFICATION OF NON-FINAL ACTION E-MAILED
2011-12-09TEAS RESPONSE TO OFFICE ACTION RECEIVED
2011-12-15ASSIGNED TO LIE
2011-12-15CORRESPONDENCE RECEIVED IN LAW OFFICE
2011-12-15TEAS/EMAIL CORRESPONDENCE ENTERED
2011-12-15SUSPENSION LETTER WRITTEN
2011-12-15LETTER OF SUSPENSION E-MAILED
2011-12-15NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
2012-06-27ASSIGNED TO LIE
2012-06-27REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
2012-06-26TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
2012-06-26CORRESPONDENCE RECEIVED IN LAW OFFICE
2012-06-27TEAS/EMAIL CORRESPONDENCE ENTERED
2012-07-06SUSPENSION LETTER WRITTEN
2012-07-06LETTER OF SUSPENSION E-MAILED
2012-07-06NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
2012-08-01ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
2013-01-09REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
2013-07-13REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
2014-01-15LIE CHECKED SUSP - TO ATTY FOR ACTION
2014-01-22TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2014-01-22ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2014-02-14NON-FINAL ACTION WRITTEN
2014-02-14NON-FINAL ACTION E-MAILED
2014-02-14NOTIFICATION OF NON-FINAL ACTION E-MAILED
2014-07-30TEAS RESPONSE TO OFFICE ACTION RECEIVED
2014-07-30CORRESPONDENCE RECEIVED IN LAW OFFICE
2014-07-30TEAS/EMAIL CORRESPONDENCE ENTERED
2014-08-18APPROVED FOR PUB - PRINCIPAL REGISTER
2014-08-19LAW OFFICE PUBLICATION REVIEW COMPLETED
2014-09-03NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2014-09-23PUBLISHED FOR OPPOSITION
2014-09-23OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2014-12-09REGISTERED-PRINCIPAL REGISTER
2015-01-21ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
2016-03-03TEAS CHANGE OF CORRESPONDENCE RECEIVED
2017-01-11AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
2018-02-21AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
2018-10-16TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2018-10-16ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2019-03-20AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
2019-07-10ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
2019-12-09COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
2020-05-03TEAS CHANGE OF OWNER ADDRESS RECEIVED
2020-05-03TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2020-05-03ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2020-05-03TEAS CHANGE OF CORRESPONDENCE RECEIVED
2020-05-03APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2021-07-16CANCELLED SEC. 8 (6-YR)